Log in
Enquire now
Xenothera SAS

Xenothera SAS

Xenothera SAS is an antibody for infection/oncology founded by Odile Duvaux.

OverviewStructured DataIssuesContributors

Contents

xenothera.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Genetics
Genetics
Therapeutics
Therapeutics
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Biology
Biology
...
Location
Nantes
Nantes
0
B2X
B2B
B2B
CEO
Odile Duvaux
Odile Duvaux
0
Founder
Odile Duvaux
Odile Duvaux
0
Pitchbook URL
pitchbook.com/profiles...169359-22
Date Incorporated
June 23, 2014
Number of Employees (Ranges)
1 – 10
Email Address
careers@xenothera.com0
Full Address
21 rue La Nouë Bras de Fer – 44200 Nantes – France0
1 rue Vauban, Nantes, France 44000, FR
Investors
Starquest Capital
Starquest Capital
CapHorn Invest
CapHorn Invest
0
EASME (EU Executive Agency for SMEs)
EASME (EU Executive Agency for SMEs)
‌
Pays de la Loire Participations
Total Funding Amount (USD)
831,629
Latest Funding Round Date
December 2016
Latest Funding Type
‌
Venture round
Country
France
France
0

Other attributes

Company Operating Status
Active

Xenothera SAS is a biotechnology company that offers a Xenotherapy platform with embedded technology that renovates immunological treatments.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Xenothera SAS

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.